Skip to main content
ConductScienceScienceDex

Harvey Cantor

NIH Rank #4720
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1864222Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$2.5M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#4,720
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Harvey Cantor. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Harvey Cantor as a PI. Multi-PI records show the full award amount for context.

  • 4R01AI165870-03R01
    Peptide-dependent mobilization of CD8 regulatory cells in cardiac transplantation
    Brigham and Women's Hospital
    $1.3M
    award amount
  • 5R01AI173307-03R01
    The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection
    Brigham and Women's Hospital
    $659.8K
    award amount
  • 5R01AG075837-02R01
    Contribution of a novel OPN-producing CD11c+ microglial subset to AD
    Dana-Farber Cancer Institute
    $495.9K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Harvey Cantor as a PI.

Brigham and Women's Hospital
MA
$2M
2 grants
Dana-Farber Cancer Institute
MA
$495.9K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Brigham and Women's Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6280
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Entered Top 25% Nationally
    Ranked #4720
  7. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  8. 2025
    R01 Grant Holder
  9. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Harvey Cantor.

Jamil Azzi
Brigham and Women's Hospital
5
shared awards

Explore further

Find collaborators for Harvey Cantor

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →